Five Questions For Quintiles India Boss
This article was originally published in PharmAsia News
Executive Summary
Things may be on the mend in India's clinical research sector, if the measured but hopeful views of Jacob Parambi, vice-president and head of Quintiles India unit, are anything to go by. The country's clinical research environment has been going through one of its most challenging phases, including evolving regulations, an ongoing Supreme Court case and a trust deficit among the lay public.